RWM
DYN icon

Rialto Wealth Management’s Dyne Therapeutics DYN Stock Holding History

Rialto Wealth Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689 Buy
+31
New +$576 ﹤0.01% 1511

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rialto Wealth Management's DYN Position: Q2 2026 in Review

Rialto Wealth Management opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 31 shares worth $689. The stake represents ﹤0.01% of the portfolio and ranks #1511 among its holdings.

246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Rialto Wealth Management held 31 shares of Dyne Therapeutics worth $689 as of Q2 2026.
  • Dyne Therapeutics was a new Rialto Wealth Management position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1511 holding.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.